Medical Foods No “Dumping Ground” For Disease Claims – FDA
This article was originally published in The Tan Sheet
FDA’s Dan Fabricant warns placing a medical food label on a dietary supplement constrained by structure/function claims does not make disease claims for the product legal. He says the agency is cracking down on products mislabeled as medical foods and on medical foods making disease claims.
You may also be interested in...
The trade group Global Organization for EPA and DHA Omega-3 petitions FDA for an unqualified health claim related to reduced blood pressure as a surrogate marker for coronary heart disease risk.
In Brief: FDA responds to Nasacort suit, acts on acetaminophen and continues medical food enforcement
FDA responds to Nasacort Allergy suit; FDA will act on lower acetaminophen dose; FDA warns consumers about wart removers; FDA continues medical food enforcement; Supplements must include declared ingredients; CHPA applauds DXM-related legislation; and USP opens Shanghai facility.
Ingredient safety, new dietary ingredient notifications, adverse event reporting, claims substantiation and disease claims are all drawing FDA attention in the supplement space, Daniel Fabricant says. Compliance for good manufacturing practices still heads the priorities for enforcement, he says.